In this era of razor-thin margins, your hospital pharmacy can be a strategic contributor. Sentri7's evidence-based guidance and tools advance medication therapy to help your team maximize its contribution by improving clinical outcomes and pharmacy cost savings.
Sentri7 pharmacy surveillance technology integrated with the EHR helps pharmacists sift through a large volume of patient data to efficiently prioritize the most important opportunities for optimizing medication therapy.
Use Sentri7's pharmacy clinical surveillance and its evidence-based rules to identify patients that need attention and alert clinicians of opportunities to improve performance, including:
Increase the impact of your pharmacy programs across facilities by using Sentri7 and its turnkey SoleSource platform to streamline adoption of programs, policies and procedures –and drive continuous improvement.
Learn more about Sentri7 Antimicrobial Stewardship and Opioid Stewardship to round out your pharmacy programs.CMS has incorporated Antimicrobial Use and Resistance (AUR) reporting to National Health and Safety Network (NHSN) as a required element under the Public Health reporting category within Promoting Interoperability Program beginning in 2024. Talk to your Quality leader about the AUR reporting requirement to determine how to avoid penalties for non-reporting.
To qualify for the Promoting Interoperability program credit, AUR reports must be submitted to the NHSN by a vendor—like Sentri7® Pharmacy AMS—certified for AUR reporting by the ONC and listed on the Certified Health IT Product List (CHPL).
One nationally-recognized pediatric hospital relies on Sentri7’s turnkey evidence-based library to establish a set of rules and metrics to strengthen the pharmacy’s impact on the hospital’s key initiatives, including its antimicrobial stewardship program (ASP) and management of drug spend.
By standardizing pharmacy clinical practices, they achieved $1.2 million in hard cost-savings and saw a 123% increase in pharmacist dose evaluations. They reduced pharmacy spending through medication therapy adjustments, increased pharmacist dose evaluations and de-escalation of high-cost medications.
